BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 20693846)

  • 1. Myeloid-derived suppressor cells in human cancer.
    Nagaraj S; Gabrilovich DI
    Cancer J; 2010; 16(4):348-53. PubMed ID: 20693846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myeloid derived suppressor cells and their role in tolerance induction in cancer.
    Fujimura T; Mahnke K; Enk AH
    J Dermatol Sci; 2010 Jul; 59(1):1-6. PubMed ID: 20570112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic targeting of myeloid-derived suppressor cells.
    Ugel S; Delpozzo F; Desantis G; Papalini F; Simonato F; Sonda N; Zilio S; Bronte V
    Curr Opin Pharmacol; 2009 Aug; 9(4):470-81. PubMed ID: 19616475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells.
    Marigo I; Dolcetti L; Serafini P; Zanovello P; Bronte V
    Immunol Rev; 2008 Apr; 222():162-79. PubMed ID: 18364001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of myeloid-derived suppressor cells to tumor-induced immune suppression, angiogenesis, invasion and metastasis.
    Ye XZ; Yu SC; Bian XW
    J Genet Genomics; 2010 Jul; 37(7):423-30. PubMed ID: 20659706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myeloid-derived suppressor cell heterogeneity in human cancers.
    Solito S; Marigo I; Pinton L; Damuzzo V; Mandruzzato S; Bronte V
    Ann N Y Acad Sci; 2014 Jun; 1319():47-65. PubMed ID: 24965257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fas signal promotes lung cancer growth by recruiting myeloid-derived suppressor cells via cancer cell-derived PGE2.
    Zhang Y; Liu Q; Zhang M; Yu Y; Liu X; Cao X
    J Immunol; 2009 Mar; 182(6):3801-8. PubMed ID: 19265159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving antitumor immune responses by circumventing immunoregulatory cells and mechanisms.
    Lizée G; Radvanyi LG; Overwijk WW; Hwu P
    Clin Cancer Res; 2006 Aug; 12(16):4794-803. PubMed ID: 16914564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the armament and appearances of human myeloid-derived suppressor cells.
    Poschke I; Kiessling R
    Clin Immunol; 2012 Sep; 144(3):250-68. PubMed ID: 22858650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myeloid-derived suppressor cell role in tumor-related inflammation.
    Dolcetti L; Marigo I; Mantelli B; Peranzoni E; Zanovello P; Bronte V
    Cancer Lett; 2008 Aug; 267(2):216-25. PubMed ID: 18433992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune responses in hepatocellular carcinoma.
    Korangy F; Höchst B; Manns MP; Greten TF
    Dig Dis; 2010; 28(1):150-4. PubMed ID: 20460904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immunosuppressive tumour network: myeloid-derived suppressor cells, regulatory T cells and natural killer T cells.
    Lindau D; Gielen P; Kroesen M; Wesseling P; Adema GJ
    Immunology; 2013 Feb; 138(2):105-15. PubMed ID: 23216602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD80 in immune suppression by mouse ovarian carcinoma-associated Gr-1+CD11b+ myeloid cells.
    Yang R; Cai Z; Zhang Y; Yutzy WH; Roby KF; Roden RB
    Cancer Res; 2006 Jul; 66(13):6807-15. PubMed ID: 16818658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myeloid-derived suppressor cells--their role in haemato-oncological malignancies and other cancers and possible implications for therapy.
    Tadmor T; Attias D; Polliack A
    Br J Haematol; 2011 Jun; 153(5):557-67. PubMed ID: 21477210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCL2/CCR2 pathway mediates recruitment of myeloid suppressor cells to cancers.
    Huang B; Lei Z; Zhao J; Gong W; Liu J; Chen Z; Liu Y; Li D; Yuan Y; Zhang GM; Feng ZH
    Cancer Lett; 2007 Jul; 252(1):86-92. PubMed ID: 17257744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL4Ralpha+ myeloid-derived suppressor cell expansion in cancer patients.
    Mandruzzato S; Solito S; Falisi E; Francescato S; Chiarion-Sileni V; Mocellin S; Zanon A; Rossi CR; Nitti D; Bronte V; Zanovello P
    J Immunol; 2009 May; 182(10):6562-8. PubMed ID: 19414811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of tyrosine kinase inhibitors in tumor immunology.
    Nishioka Y; Aono Y; Sone S
    Immunotherapy; 2011 Jan; 3(1):107-16. PubMed ID: 21174561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-13-regulated M2 macrophages in combination with myeloid suppressor cells block immune surveillance against metastasis.
    Sinha P; Clements VK; Ostrand-Rosenberg S
    Cancer Res; 2005 Dec; 65(24):11743-51. PubMed ID: 16357187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myeloid-derived suppressor cells in inflammatory bowel disease: a new immunoregulatory pathway.
    Haile LA; von Wasielewski R; Gamrekelashvili J; Krüger C; Bachmann O; Westendorf AM; Buer J; Liblau R; Manns MP; Korangy F; Greten TF
    Gastroenterology; 2008 Sep; 135(3):871-81, 881.e1-5. PubMed ID: 18674538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of anti-cancer immunity by regulatory T cells: back to the future.
    Orentas RJ; Kohler ME; Johnson BD
    Semin Cancer Biol; 2006 Apr; 16(2):137-49. PubMed ID: 16376101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.